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Graphical abstract 10 
Designed hybrid aerogels (silica & gelatin) for immediate and sustained release of hydrophobic acid drugs. 11 
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Abstract 15 
A comprehensive study of 14 hybrid aerogels of different composition with applications in drug delivery has been carried out. The overall objective 16 
was to modulate the release behavior of drug-impregnated aerogels, from an almost instantaneous release to a semi-retarded delivery prolonged during 17 
 2 
 
several hours, through internal surface functionalization. The designed hybrid aerogels were composed of silica and gelatin and functionalized with either 18 
phenyl, long (16) hydrocarbon chain or methyl moiety. As model systems, three class II active agents (pKa < 5.5), ibuprofen, ketoprofen and triflusal, were 19 
chosen to impregnate the aerogels. The work relied on the use of supercritical fluid technology for both the synthesis and functionalization of the hybrid 20 
aerogels, as well as for the impregnation with an active agent using supercritical CO2 as a solvent. For the impregnated aerogels, in vitro release profiles 21 
were recorded under gastric and intestinal pH-conditions using HPLC techniques. The release behavior observed for the three studied drugs was explained 22 
considering the measured dissolution profiles of the crystalline drugs, the aerogel composition and its functionalization. Such features are considered of 23 
great interest to tailor the bioavailability of drugs with low water solubility. 24 
 25 
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1. Introduction 28 
Silica aerogel based systems constitute an emerging and promising platform for drug delivery applications, principally due to their high drug loading 29 
capacity, their capability to increase the bioavailability of hydrophobic drugs and even to improve drugs stability (Pierre and Pajonk, 2002; Smirnova et al., 30 
2004; Ulker and Erkey, 2014; Agostini et al., 2015; Malode et al., 2015). Functionalization, hybridization and coating methods have been developed to 31 
protect silica aerogels for long term use, importantly, to avoid pore collapse in a wet environment (Soleimani-Dorcheh and Abassi, 2008; Murillo-Cremaes et 32 
al., 2014). In the pharmaceutical field, the preparation of porous organic and hybrid aerogels has increased their performance in applications related to 33 
controlled release (García-González et al., 2011), thus becoming a clear alternative to polymers as drug delivery vehicles. In this scenario, the overall 34 
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objective of this research was to design hybrid and surface functionalized aerogels, with the ability of tailoring the drug release behavior from an almost 35 
instantaneous release to a semi-retarded delivery prolonged during several hours. 36 
Hybrid composite materials are always attractive, since they can combine diverse physicochemical characteristics in one entity (Hoffmann et al., 37 
2006). For aerogels, coupling the high surface area of inorganic mesoporous silica with the biodegradable nature of organic constituents has led to high 38 
performance novel materials (Molvinger et al., 2004; Ramadan et al., 2010). For biomedical applications, natural biocompatible polymers are promising 39 
candidates as organic constituents. These biopolymers (e.g. proteins, polysaccharides) are, in their majority, biodegradable, available in large amounts and 40 
relatively cheap (Babu et al., 2013). Usually, they possess hydroxyl or amine groups capable of establishing inter- and intra-molecular hydrogen bonds. Due 41 
to the existence of these groups, such polymers interact strongly with water and have the capacity to form hydrogels (Oh et al., 2009; Tsioptsias et al., 42 
2011). However, they have almost not been explored to obtain hybrid silica aerogels, and only the system chitosan/silica has been recently described (Ayers 43 
and Hunt, 2001; Molvinger et al., 2004). In this work, gelatin is used as the organic component to form hybrid silica aerogels following a sol-gel procedure 44 
and supercritical alcogel drying. Gelatin is a biopolymer derived from the hydrolysis of collagen obtained from various animal by-products. This polymer has 45 
been used as a delivery vehicle for the release of bioactive molecules and in the generation of scaffolds for tissue engineering applications (Frydrych et al., 46 
2011; Aristippos, 2002).   47 
The modification of the internal surface of mesoporous aerogels with specific functional groups influences the adsorption capacity and/or alters the 48 
release properties of the matrix (López-Aranguren et al., 2012; Alnaief and Smirnova, 2010; Builes et al., 2012). Hence, in this research surface modification 49 
by hydrophobic functionalization was further explored to modulate hybrid aerogel characteristics. The two different strategies used for this purpose were in 50 
situ co-condensation during silica hydrolysis with hydrophobic moieties (phenyl or C16 hydrocarbon chain) and post-gelation derivatization with 51 
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hydrophobic silanes. Hydrophobic functionalization is applied not only to alter the aerogel surface charge and reactivity (García-González et al., 2009), but 52 
often to enhance aerogel stability in wet environments (Rao et al., 2005).  53 
In an effective drug delivery protocol, drug dissolution is the prerequisite for drug absorption in the body to get the subsequent clinical response, 54 
especially for drugs administered orally. However,  around  70 % of the drugs in the R&D pipeline fit into class II in the Biopharmaceutics Classification 55 
System (BCS),  presenting low solubility and low oral bioavailability (Huang and Brazel, 2001; Acharya and Park, 2006). For those active agents, if 56 
administered in the crystalline form, drug absorption is often rate limited by in vivo drug dissolution. Poorly water soluble drugs tend to be eliminated from 57 
the gastrointestinal tract before they get the opportunity to be fully dissolved and absorbed into the blood circulation system. Dose augmentation would be 58 
necessary to ensure that the drug attains the therapeutic concentration range in blood although it can cause toxicity and side effects. Introducing upgraded 59 
or advanced formulations is the approach to enhance biodisponibility for these drugs. Physical modifications, such as particle size reduction of amorphous 60 
synthesis, often aim to increase the surface area, solubility and wettability of the drug particles. Different proposed strategies are those based on the 61 
formulation of solid mixtures or matrix dispersions (Rasenack and Müller, 2004; Kerc et al., 1999; Elvira et al., 2004). Poorly water soluble crystalline drugs 62 
are preferentially formulated as molecular dispersions in porous matrices. In these conditions, drug biodisponibility is increased because no energy is 63 
required to break up the crystal lattice during dissolution. Moreover, matrix systems with a more retarded profile can be used to maintain the therapeutic 64 
dosage for a long period of time, thus, reducing the necessity of frequent dosage and increasing patient compliance.  65 
Due to the highly porous structure of hybrid aerogels, they have been proposed as carrier matrixes for the molecular dispersion of poorly water-66 
soluble drugs (Smirnova et al., 2004; Ulker and Erkey, 2014, García-González et al., 2011; Alnaief and Smirnova, 2010). In this study, drugs chosen for 67 
analysis are class II weak acids, namely ibuprofen (Ibu), ketoprofen (Ket), and triflusal (Trf). These active agents were used to characterize the drug delivery 68 
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capabilities of the synthesized aerogels. Triflusal is an irreversible inhibitor of the enzyme cyclo-oxygenase and it is commonly used as a platelet anti-69 
aggregant preventer for the treatment of thrombosis diseases. Ibuprofen and ketoprofen are propionic acid derivatives belonging to the nonsteroidal anti-70 
inflammatory drugs family with analgesic and antipyretic effects. 71 
The unique properties of scCO2 have been advantageously exploited to prepare molecular dispersions of poorly water-soluble drug substances into 72 
porous matrices, since a high solubility of low molecular weight hydrophobic compounds in scCO2 is, usually, found (Martín and Cocero, 2008; Yasuji et al., 73 
2008). The benefit of using scCO2 as the impregnation medium to fabricate host–guest systems has been previously demonstrated on polymeric (Kikic and 74 
Vecchione, 2003; Uzer et al., 2006; López-Periago et al., 2008) and inorganic matrices (Cooper, 2003; García-Carmona et al., 2002; Shin et al., 2000; López-75 
Aranguren et al., 2013; López-Periago et al., 2010). The avoidance or little use of organic solvents, the intrinsic sterility of scCO2 and the fact that the final 76 
product is in a dry form and is produced in confined autoclaves are also of particular interest for pharmaceutical products manufacturing (Schutz, 2007). The 77 
objective of this study was, therefore, the use of a generic supercritical fluid technology for the synthesis and drug impregnation of hybrid aerogels. For the 78 
aerogels synthesized, functionalized and impregnated in this work, two processing characteristics of the supercritical fluid technology make the method 79 
significantly more efficient than when applying other more conventional liquid solvents. First, the null surface tension of a supercritical fluid allows the 80 
drying of alcogels preserving their porosity to form aerogels (Wagh et al., 1999; Yoda and Ohshima, 1999). Second, due to the low viscosity and high 81 
diffusivity of fluids under supercritical conditions, scCO2 solutions have the ability to penetrate and efficiently impregnate porous matrices with organic 82 
solutes, in this work selected model drugs, again without damaging the porous structure (Domingo et al., 1998; Murillo-Cremaes et al., 2010). 83 
The quantification of the amount of drug entrapped and the characterization of the release profiles were carried out by high performance liquid 84 
chromatography (HPLC) in aqueous media at pHs 6.7 and 2.0. The use of hydrophilic aerogels resulted in either a fast or semi-retarded release as a function 85 
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of pH. Contrarily, the functionalization of the aerogels with hydrophobic moieties resulted in more prolonged release lasting several hours at both studied 86 
pHs.  87 
  88 
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2. Materials and methods 89 
2.1 Materials 90 
Tetramethylorthosilicate (TMOS) and gelatin, the components of the hybrid aerogels, were obtained from Fluka and Dr. Oetker, respectively. 91 
Methanol and acetone were used as the solvents for aerogel synthesis and ammonium carbonate ((NH4)2CO3) was added as a pH controller, all from Fluka. 92 
The aerogel surface modifying agents were hexadecyltrimethoxysilane (C16-TMOS),  phenyltrimethoxysilane (Ph-TMOS) and hexamethyldisilazane (HMDS), 93 
all of them supplied by Sigma-Aldrich. 2-(4-(2-methylpropyl)phenyl)propanoic acid (Ibu) and 2-(3-benzoylphenyl)propanoic acid (Ket) were purchased from 94 
Sigma Aldrich, while 2-acetyloxy-4-trifluoromethyl benzoic acid (Trf) and its main metabolite 2-hydroxy-4-trifluoromethyl benzoic acid (HTB) were kindly 95 
donated by Uriach S.A. The molecular structure of modifying agents and used drugs is shown in Fig. 1a and b, respectively. CO2 (99.995 %, Carburos 96 
Metalicos S.A.) was used as the processing solvent. Milli-Q water (Millipore), formic acid (99% w/w, Merck) and methanol (HPLC grade, Panreac) were used 97 
for the preparation of the mobile phase for the chromatographic method. 98 
2.2 Methods 99 
2.2.1 Aerogel synthesis 100 
Hybrid alcogels were prepared by a sol-gel procedure using different organic/inorganic phase percentage. Reagents weight used to synthesize the 101 
different studied aerogels are shown in Table 1. In a typical procedure, a given quantity of solid gelatin was first dissolved in hot water, then the solution 102 
was cooled to room temperature before adding the corresponding amount of (NH4)2CO3. A viscous solution was obtained by applying vigorous stirring, to 103 
which TMOS dissolved in methanol was added. In selected experiments, a weighted amount of either Ph-TMOS or  C16-TMOS functionalizing agent was 104 
added at this point in a fraction of ca. 10, 20 and 30 v/v% with respect to TMOS. After several minutes of stirring, TMOS hydrolysis and condensation 105 
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produced a single phase mixture, which was poured in plastic containers to allow gelation to develop for a period of 24 h. Samples were next placed into 106 
perforated aluminium containers and a multiple step solvent exchange protocol was carried out consisting on: first, samples were soaked in methanol for 24 107 
h to remove water; second, methanol was replaced by acetone in two 24-h soaking steps; and finally, the acetone was extracted with scCO2 at 14 MPa and 108 
80 ºC (Lázár et al., 2015). Most likely, some of the added gelatin is eliminated from the system dissolved in the aqueous phase during the multiple steps 109 
solvent exchange procedure needed to dry the aerogels. For post-silanized samples, the HDMS reagent was added after the first soaking step with 110 
methanol, and the system alcogel/HDMS was additionally aged during 48 h.  Monolithic pieces of a dry aerogel were obtained in all cases, which were 111 
further mechanically micronized to obtain a powder. 112 
2.2.2 scCO2 impregnation procedure 113 
The drug loading process in scCO2 was performed in a high pressure equipment described elsewhere (Murillo Cremaes et al., 2013). Experiments 114 
were carried out in the batch mode. In a typical run, the autoclave (100 mL) was charged with powdered aerogel wrapped in a cylinder made of 0.45 µm 115 
pore filter paper. An excess of drug (Ibu, Ket or Trf) was added at the bottom of the reactor, thus ensuring saturation of the scCO2 phase. Following this 116 
experimental design, matrix and drug maintained a physical separation into the autoclave. The reactor was then filled with liquid CO2 and heated up to 45 117 
ºC. The system pressure was increased to 12 MPa for the highly soluble Trf and to 20 MPa for Ibu and Ket. The autoclave was magnetically stirred at 100 118 
rpm for a period of 6 h, after which the reactor was depressurized and the loaded aerogel was recovered. The depressurization rate was 0.2-0.3 MPa min-1 119 
to avoid drug crystallization. 120 
2.3 Characterization 121 
2.3.1 Solid characterization 122 
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The thermal behavior of hybrid aerogels and the quantification of the loaded modifiers and drugs were assessed by thermogravimetric analysis 123 
(TGA) using a Perkin Elmer 7 TGA instrument. Thermal transitions were studied by differential scanning calorimetry (DSC) with a Mettler Toledo 822e/400 124 
instrument. Both kinds of measurements were carried out under N2 atmosphere at a 10 ºC min−1 heaƟng rate. The crystallinity of the loaded drugs was 125 
analyzed by X-ray powder diffraction (XRD)  using a Rigaku Rotaflex RU-200 B spectrometer. Textural characteristics of bare and impregnated matrices were 126 
studied by low-temperature N2 adsorption–desorption analysis (ASAP 2000 Micromeritics Inc.). Prior to measurements, samples were dried under reduced 127 
pressure (<1 mPa) at 80 ºC for 24 h. Specific surface area (as) was determined by the BET method. The volume (Pv) was determined from the N2 adsorption 128 
isotherm using the BJH method.  129 
2.3.2 HPLC characterization 130 
The liquid chromatograph equipment consisted of an Agilent 1100 series instrument furnished with a G1311 quaternary pump, a G1379A degasser, 131 
a G1392A autosampler and a G1315B diode array spectrophotometric detector. Instrumental control and data acquisition and treatment were carried out 132 
with a PC using the Agilent Chemstation software. The analytical column was a Synergy Hydro-RP C18 (150 mm×4.6 mm i.d., particle size 4 µm) from 133 
Phenomenex. Analytes were eluted isocratically using 0.1 v/v% formic acid aqueous solution and methanol. The percentage of methanol in the eluent was 134 
80 v/v%  for Trf/HTB and Ket, and 90 v/v% for Ibu. The mobile phase flow rate was 1 mL min-1 and the injection volume was 10 μL. Trf/HTB, Ket and Ibu 135 
were detected at 280, 254 and 220 nm, respectively. A complete description of the procedure can be found in (Argemí et al., 2008). This procedure was 136 
used in the determination of the percentage of impregnation and in the monitoring of the drug release. 137 
 HPLC methods were first applied to quantify the overall amount of drug loaded in the different aerogel samples. The percentage was determined 138 
after soaking a weighed sample amount (~ 5-10 mg) in 10 mL of methanol. 10 µL of the resulting solutions were injected in the column of the 139 
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chromatographic system. In the case of Trf/HTB systems, concentrations of both drug and metabolite were quantified and data presented in this work 140 
corresponded to the sum of both values, expressed as the total triflusal (Trf(T)). 141 
HPLC analysis was also used to follow the kinetics of drug dissolution for pristine drugs and of drug release for selected aerogel samples. The drug 142 
delivery profiles were evaluated in both 10 mM HCl (pH 2.0) and 50 mM hydrogenphosphate / dihidrogenphosphate buffer (pH 6.7) aqueous solutions, thus, 143 
simulating gastric and intestinal pH-condition, respectively. In these experiments, a weighed sample  (~ 5-7 mg) was added to 25 mL of preheated  (37 +/- 144 
0.5 °C) buffer solution. The stirring rate and temperature were fixed at 60 rpm and 37 ºC, respectively. For each measurement, 250 µL buffer was recovered, 145 
and 10 µL were injected into the column. Assays were performed in triplicate that allowed the release profiles and variability ranges to be established. 146 
  147 
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3. Results and discussion 148 
3.1 Aerogels composition 149 
Four different gelatin:silica precursor weight ratios, between 3 and 30 wt%, were added to the reactor to synthesize the hybrid aerogels (Table 1). In 150 
particular, ratios of 3, 10, 20 and 30 wt% were used to synthesize samples referred as H3, H10, H20 and H30, respectively. The gelatin mass incorporated in 151 
these hybrid aerogels after processing was estimated by TGA from the weight loss in the range 300-500 ºC (Fig. 2a). In this temperature interval, some 152 
condensation of vicinal -OH groups could also take place in the inorganic silica phase. However, the lost of weight in this range due to the lost of water 153 
molecules expelled by the inorganic phase is below 1 wt% and has was considered negligible (Murillo-Cremaes et al., 2013). The TGA estimated weight 154 
percentage of gelatin in hybrid aerogels is given in Table 2. This ratio was from ca. 3 to 24 wt% in samples with the lowest (H3) and the highest amount of 155 
added gelatin (H30).  156 
The gelatin/silica aerogels are hydrophilic porous materials. To obtain products with different characteristics and applications, the hybrid aerogels 157 
were further modified by functionalization on the surface. Two different functionalization approaches were evaluated, applied either during the sol-gel 158 
process or after gelation. In the first method, aerogels with a low percentage of gelatin (H3), were modified during the sol-gel reaction by co-condensation 159 
of TMOS and either Ph-TMOS (sample H3_Ph) or C16-TMOS (sample H3_C16) added in a ratio of TMOS:functionalizing agent of 90:10, 80:20 or 70:30 v/v% 160 
(Table 1). For the two studied TMOS additives, a hydrophobic group was incorporated into the silica matrix via a hydrolytically stable Si-C covalent bond (O-161 
Si-Ph or O-Si-C16H33) (Wei et al., 2004; Hegde and Rao, 2006). In the second tactic, the hybrid gel was post-functionalized after aging, but before drying, 162 
by adding HMDS, a difunctional trimethylsilyl silane that is known to be highly reactive with surface silanols, giving ammonia as a side product (Rao et al., 163 
2004). In this case, the hydrogen in the surface silanol groups is replaced by the hydrolytically stable O-Si-(CH3)3 group (Kartal and Erkey, 2010). Following 164 
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this procedure, hybrid aerogels with different silica:gelatin ratios were derivatized by adding an excess of the silylation component, in a weight percentage 165 
close to 50 wt% with respect to the added weight of aerogel TMOS and gelatin components.  166 
TGA was used to estimate the final composition of the functionalized aerogels. Gelatin decomposition was previously established to occur between 167 
300 and 500 ºC (Fig. 2a). The degradation temperature of modifiers used depends on the chemical structure of the grafted molecules. Fig. 2b shows the TGA 168 
profiles corresponding to H3 aerogels treated with each one of the studied modifiers. For Ph-TMOS and HMDS treated aerogels, the hydrolytically stable 169 
Si-C covalent bond in the Si-Ph and Si-(CH3)3 layers remained intact up to 550 ºC. As a consequence, for these samples the weight loss occurred in two 170 
uneven stages: the first one corresponded to gelatin degradation (300-500 ºC) and the second resulted from the Si-C cleavage occurring in the 550-700 ºC 171 
temperature interval. From the TGA weight loss in the second temperature interval, it could be estimated that aerogel samples were modified with ca. 4-9 172 
and 5-6 wt% of -Ph and -(CH3)3 organic moieties, respectively (Table 2). In contrast, for the aerogel modified with -C16 (H3_C16 samples) the grafted 173 
hydrocarbon chain starts to decompose by cleavage of C–C bonds at ca. 250-300 ºC and continue up to 700 ºC, temperature interval in which the Si-C bond 174 
is broken. Therefore, the weight loss of gelatin and modifier were overlapped. Assuming a gelatin loss of weight of ca. 4 wt% in the H3 type samples, the 175 
estimated amount of C16 modifier incorporated to the sample was ca. of 2-6 wt% (Table 2).  176 
The grafted modifiers have remarkably different molecular weight values (Mw), namely: 77, 225 and 45 g mol-1 for -C6H5 (Ph), -C16H33 (C16) and -177 
(CH3)3 (HMDS), respectively, which would result in different surface molecular densities for similar weight percentages of incorporated product. To 178 
facilitate comparison, molecular surface densities (S) were calculated by using the BET values of the specific surface area of the raw matrices (as [nm2 g-1]) 179 
and the TGA measured amount of deposited modifier (ds [g(modifier) g-1] (Table 2). Surface grafting density was calculated using the formula: 180 
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Relatively high density values of 1.0-1.7 molecule nm-2 were estimated for the silanized products, and of 0.5-1.0 molecule nm2 for -Ph treated 182 
aerogels. On the contrary, aerogels functionalized with the long carbon chain -C16 had surface grafting density values of only 0.1-0.2  molecule nm2. 183 
3.2 Microstructure and textural properties of aerogels 184 
The microstructure of the prepared composite aerogels was studied in regard of their morphology and textural properties. Pictures of sample H20, 185 
with a fairly high gelatin content (18 wt%), are shown in the SEM pictures of Fig. 3. Only the microstructure typical of silica aerogel can be observed in the 186 
images. No separate polymer phase was visible in any portion of the sample, thus indicating that the two phases were intimately mixed at this scale. The 187 
measured percentages of gelatin in the hybrid aerogels (Table 2) were similar to the added amounts (Table 1), suggesting the full incorporation of this phase 188 
to the silica primary particles. Sol-gel nanocomposites were formed as colloidal hybrid sol particles, which subsequently aggregated to gels and resulted in 189 
aerogels after drying (Watzke and Dieschbourg, 1994).  190 
Silica aerogels possess a wide variety of extraordinary properties, including very high porosity (95-99 %) and pore volume (2.5-3 cm3 g-1), high 191 
specific surface area (700-1500 m² g-1) and mesoporosity. Often, hybrid aerogels have lower values of textural properties than pristine silica, but still they are 192 
obtained as highly porous materials in the mesopore range. The N2 adsorption/desorption isotherms recorded for the hybrid aerogels synthesized with 193 
different gelatin dosages had a type IV profile (IUPAC classification), characteristic of mesoporous materials, including also macropores. Table 2 reports the 194 
textural data for hydrophilic H3-H30 hybrid aerogels. For sample H3, with the lowest gelatin content, the surface area and pore volume were ca. 700 m2 g-1 195 
and 2.1 cm3 g-1. By increasing the percentage of gelatin in the sample, these values decreased to ca. 300 m2 g-1 and 1.2 cm3 g-1 in H30, but still maintained the 196 
mesoporous characteristics and the high surface area values. Irrespective of the aerogel composition, the mean pore diameter value was in the order of 197 
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magnitude of 15 nm. Finally, functionalization of the aerogels surface by co-condensation (H3) or silane derivatization (H3 and H20) did not have a significant 198 
influence in the measured values of both the specific surface area and pore volume when compared to non-functionalized similar aerogels (Table 2).  199 
In the N2 adsorption measurements, the intensity of the interaction of the adsorbate with the surface of the adsorbent can be assessed from the C 200 
constant of the BET equation (Sing, 1998). Although rigorous interpretation of the C parameter, combined with its use for the determination of surface 201 
energies, has fundamental limitations, this simplistic qualitative approach gives an idea of the hydrophobic/hydrophilic degree of the adsorbent surface: the 202 
lower the C constant value, the lower the hydrophilicity. Pure silica aerogels have values of C of ca. 100. As it can be observed in Table 2, hybrid H3-H30 203 
aerogels prepared in this work presented values of C in the order of 80, independently of the gelatin content, indicating hydrophilic compounds. The C values 204 
for the -Ph modified aerogels (H3_Ph) and silylated samples (H3_sil, H20_sil) were reduced to ca. 30-50, pointing towards a decrease of the aerogel surface 205 
polarity, which is the result of the presence of the hydrophobic functionalizing agent. In contrast, C values measured for the -C16 modified aerogel (H3_C16) 206 
were similar to those corresponding to the pristine hybrid matrix H3, likely reflecting the low surface grafting density values estimated for this modifier (0.1-207 
0.2 molecule nm-2), not enough to significantly modify the thermodynamic properties of the aerogel surface.  208 
3.3 Impregnated aerogels 209 
The hybrid aerogel systems described previously were impregnated with Ibu, Ket or Trf  by using scCO2 as a solvent. The high hydrophobicity of 210 
these drugs makes them soluble in scCO2 at 35-45 °C and pressures above 90 bar. The solubility of ibuprofen in scCO2 was found to be in the order of 211 
4x10−3 mole fracƟon at 20 MPa and 35 ºC (Charoenchaitrakool et al., 2000). Under similar conditions, the solubility of ketoprofen was reduced to a value of 212 
8x10-5 mole fraction (Macnaughton et al., 1996). The lower solubility value found for ketoprofen with respect to ibuprofen was linked to the high molecular 213 
weight of the former. For triflusal, the presence of the hydrophobic trifluoromethyl group renders a pronounced effect in the interaction of Trf molecules 214 
with scCO2 enhancing the solubility to values of 3×10−2 mole fracƟon at 35 ºC and 20 MPa (López-Periago et al., 2009). 215 
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After scCO2 impregnation, the first estimation of drug loading values was performed by TGA. Illustrative TGA profiles, corresponding to aerogel H3 216 
loaded with any of the three studied drugs (e.g. Ibu@H3, Ket@H3 and Trf(T)@H3), are shown in Fig. 4a. Impregnation values were roughly calculated from 217 
the weight loss in the interval 150-550 ºC, after subtracting the fraction corresponding to the matrix (gelatin) weight loss (ca. 4 wt%). Following the 218 
described scCO2 impregnation procedure, high loading values were found, in the order of 19, 13 and 27 wt% for Ibu@H3, Ket@H3 and Trf(T)@H3 samples, 219 
respectively. These loadings are considered as particularly high for systems in which the drug is not deposited in the form of either crystalline or amorphous 220 
particles.  Higher drug loading values have been reported, but involving the formation of crystals inside of the aerogel pores (Rajanna et al. 2015, Gorle et al. 221 
2008). In order to confirm the loading percentages, more accurate determination relying on HPLC analysis from three independent replicates was 222 
conducted. Results given in Table 2 are those obtained from HPLC measurements. Note that for impregnated H3 samples, loading values estimated by either 223 
TGA or HPLC were similar. The highest loading values were obtained for Trf(T) drug (ca. 25-29 wt%), followed by Ibu (ca. 19-24 wt%) and Ket with the lowest 224 
loading values (ca. 11-15 wt%). 225 
XRD was used to assess the occurrence or the absence of a crystalline arrangement for the impregnated drugs. Spectra were recorded in the 2 226 
range of 5-35º and for low gelatin content matrices H3 they are shown in Fig. 4b. The three studied drugs could be readily identified in this range by their 227 
most intense peaks (Fig. 4b). For the three studied drugs loaded into H3 aerogels, spectra showed only a broad band centered at ca. 22º, which was typical 228 
of amorphous silica. Diffraction peaks corresponding to Trf, Ibu or Ket crystalline forms were not detected in the XRD patterns of the composite products. 229 
This result indicates the absence of drug crystallization inside of the aerogel pores after supercritical impregnation. Complementarily, DSC analysis (not 230 
shown) was used to further confirm the absence of drug crystals or amorphous forms in these products. Within the studied DSC temperature interval (up to 231 
450 ºC), thermal transitions were inexistent for the studied H3 matrices, as well as for this matrix loaded with the different drugs. Unsupported drugs melt 232 
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in the 80-120 ºC temperature interval exhibiting a sharp endothermic peak in the DSC spectra. Hence, XRD and DSC results suggested that the drug was 233 
most likely dispersed inside the matrices at a molecular level, rather than in the crystalline or amorphous solid form (Kazarian and Martirosyan, 2002; López-234 
Periago et al., 2009). In fact, to generate crystalline particles inside of the pores a sudden change in solubility, created, for instance, by fast pressure release, 235 
has been described as necessary (Gorle et al., 2010).  236 
Synthesized hybrid aerogel are highly hydrophilic, having a high number of surface -OH and -NH groups. These reactive surface moieties may be able 237 
to form hydrogen bond with the carboxylic acid groups of studied drug molecules, which favored the molecular dispersion and stabilized thermally the drugs 238 
against degradation, since TGA analysis showed that they were stable up to temperatures of 300 ºC and higher (Fig. 4a). For these samples, the textural 239 
properties were also modified after drug impregnation, resulting in a reduction of the specific surface area and pore volume to values of ca. 400-450 m2 g-1 240 
and 1.5-1.6 cm3 g-1, respectively, which likely account for the space occupied by the drug molecules. Moreover, the given C values were in the order of 30-241 
40 for H3 impregnated matrices, which were in the range of approximately half of the value of the raw H3 aerogel (Table 2), indicating surface 242 
hydrophobization by drug impregnation. 243 
The influence of aerogel functionalization on drug loading was further studied by HPLC (Table 2). For hydrophilic matrices, constituted exclusively by 244 
silica and gelatin, the gelatin percentage did not have any significant influence on drugs uptake at the studied silica:gelatin ratios (Fig. 5a). The effect on the 245 
drug uptake when modifying the aerogel with the -Ph (Fig. 5b) or -C16 (Fig. 5c) hydrophobic agent was found to be negligible for any of the three drugs 246 
studied. For these systems, impregnated values were in the order of 18-27, 7-18, 19-29 wt% for Ibu, Ket and Trf(T), respectively (Table 2). For the -C16 247 
modified aerogels, this result can be attributed to the low attained surface grafting density, but it was surprising for the -Ph modified products. Contrarily, 248 
formation of hydrophobic gelatin-silica aerogels by exposition to hexamethyldisilazane and further drug impregnation resulted, in general, in materials with 249 
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a lower amount of adsorbed drugs than the raw matrices (Fig. 5d). Loading differences were more significant for Ibu and Ket drugs than for Trf(T). The 250 
decrease in the uptake can be related to the reduction of the drug adsorption sites already occupied by silyl moieties. 251 
3.4 Drug dissolution and release profiles 252 
Drug dissolution profiles of pristine drugs and loaded aerogel systems were monitored in vitro according to the HPLC methodology described in 253 
section 2.3. Assays were carried out in two dissolution media, biorelevant and widely applied to similar studies, with a pH of either 6.7 (intestinal pH) or 2.0 254 
(gastric pH). A preliminary dissolution test was carried out for each pristine drug under similar pH conditions (Fig. 6). Crystalline drugs were rapidly dissolved 255 
in the first few minutes, either totally (basic pH) or up to saturation values (acid pH). This is the common behavior expected for the studied acidic drugs, 256 
with pKa values of 4.40, 4.76 and 4.15 for Ibu, Ket and Trf, respectively (Sheng et al., 2009). Performed measurements gave an estimation of drugs solubility 257 
under studied experimental conditions: at pH 2 and 37 ºC, measured solubility values were in the order of 0.06, 0.26 and 0.69 mg mL-1 for Ibu, Ket and 258 
Trf(T), respectively, while at pH 6.7 and 37 ºC, the solubility of the three compounds was higher than 0.7 mg mL-1, which was the highest value assayed. The 259 
observed increase in dissolution at pH 6.7, particularly evident for Ibu and Ket active agents (Fig. 6a,b), was related to an enhanced driving force for the 260 
forward reaction between the weakly acid drug and the basic species in the medium. The Trf behavior was more complex (Fig. 6c), since aside from 261 
solubility issues, this molecule is unstable at neutral and alkaline pH (Ferrit et al., 2008) undergoing a progressive decomposition to HTB (Argemí et al., 262 
2008). The metabolite HTB is also highly active as a platelet aggregation inhibitor, hence, its degradation does not represent a remarkable shortcoming from 263 
a pharmaceutical point of view. However, analytically this decomposition makes more difficult the evaluation of the behavior of the drug in aqueous media. 264 
The drug release profiles were studied for samples involving either a hydrophilic (H3) or hydrophobic (H3_sil) matrix. Drug release profiles from the 265 
hydrophilic H3 matrix are shown in Fig. 7. At pH 6.7, drug dissolution for the three studied active agents occurred almost instantaneously (Fig. 7a-c). On the 266 
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contrary semi-retarded release profiles were recorded at pH 2.0. For Ibu at pH 2.0, a release of drug of ca. 50 % was observed in a first burst stage, followed 267 
of a slow delivery step giving ca. 70 % of drug released after 5 h of dissolution test (Fig. 7a). For Ket at pH 2.0, the initial burst release attained a value as 268 
high as 80 % and after 5 h the drug was completely released to the acid media (Fig. 7b). For Trf(T) at pH 2.0, the initial burst provided an immediate relief of 269 
40 % of the loaded drug, reaching a value of drug dissolution of 90 % after 5 h of test (Fig. 7d). It is worth mentioning that the dissolution rate for the three 270 
studied drugs from the H3 matrix was faster in basic medium than at pH 2.0, which corresponded to the medium with the measured lowest solubility values. 271 
Hence, the observed semi-retarded release behavior under acidic conditions could not be related to drug solubility, but to the specific interaction 272 
established between the matrix and each drug as a function of pH. Analytes studied are quite apolar (the estimated logP values for Ibu, Ket and Trf are 3.7, 273 
2.8 and 2.3, respectively) and are mainly protonated (neutral) at pH 2.0, while at pH 6.7 the deprotonated (anionic) species of all the drugs are present as 274 
the major species. The protonated species mainly occurring a pH 2.0 seems to interact more strongly with the hydroxylated matrix surface, probably 275 
through hydrogen bonds, thus, retarding drug release. 276 
In Fig. 7c,d, the separate Trf and HTB curves are shown at the two studied pHs, together with the total triflusal drug release profiles. The 277 
percentages of Trf and HTB inside of the matrices were calculated from the corresponding chromatographic peaks at the initial stages of the release. Those 278 
values were considered to mirror the degree of hydrolysis of the encapsulated drug, and were related to the percentage of drug degradation during 279 
preparation and storage. As shown in Fig. 7c,d, the molar percentage of Trf hydrolysis to HTB in the hydrophilic aerogels was about 10 mol%. Found values 280 
were consistent with the values obtained in the instantaneous HPLC dissolution process carried out to quantify the overall amount of drug loaded in the 281 
different aerogel samples. It is noteworthy that the degree of hydrolysis was relatively low, being the Trf well preserved inside the hydrophilic aerogel 282 
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matrices. This behavior was attributed to the acidity provided to the adsorbed water by the SiO2 matrix, which in turns stabilized the Trf molecules against 283 
hydrolysis. At pH 6.7, Trf transformation to HTB continued during the dissolution test, reaching a value of almost 20 mol% after 120 min (Fig. 7c).  284 
The role of modifiers in the silica aerogel, including gelatin in the bulk and hydrophobic agents on the surface, is analyzed by comparison with 285 
published data for pure silica aerogels having surface areas of 600-800 m2g-1 and drug loadings in the order of 10-20 wt%. For the ibuprofen@silica aerogel 286 
system, release data is published at neutral pH showing a delivery of 80 % of the drug after 30 min (Mehling et al. 2009). For the ibuprofen@H3 system 287 
studied in this work, the release of 80 % was attained after 10 min in neutral pH and retarded to more than 300 min at acid pH. For the ketoprofen@silica 288 
aerogel system, it has been shown that 60 min are necessary to release 80 % of the drug at acid pH (Smirnova et al. 2004), similar to the value found in this 289 
work for the ketoprofen@H3 system. For the TRF@silica aerogel system, previous studies showed that 80 % of the drug was released after 20 min in both 290 
acid and basic pH (Murillo-Cremaes et al. 2013). However, for the TRF@H3 samples, periods of 60 and >300 min were necessary to reach a delivery of 80 % 291 
at neutral and acid pH, respectively. 292 
The release behavior of the hydrophobic drugs dispersed in modified hydrophobic aerogels was assessed in the matrix with the lowest gelatin 293 
content treated with HDMS (H3_sil sample). For the three studied drugs, a prolonged release over time was observed for the impregnated drug@H3_sil 294 
samples when compared to the release profiles of similar drug@H3 aerogels (Fig. 8). This behavior was observed at both of the studied pHs. The described 295 
fast release observed for the drug@H3 samples at pH 6.7 turned into a two-step release profiled in similar drug@H3_sil samples, involving an initial burst of 296 
40, 15 and 20 % release for Ibu, Ket and Trf(T), followed of a slow delivery reaching values of 75, 35 and 80 % release for Ibu, Ket and Trf(T) after 5h (Fig. 297 
8a,b,c). At pH 2, similar initial burst values than at pH 6.7 were noticed for drug@H3_sil samples, although a slightly slower drug release was measured at 298 
the acidic pH. At pH 2, values of only 55, 30 and 65 % release were measured for Ibu, Ket and Trf(T) after 5 h (Fig. 8a,b,d).  299 
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4. Conclusions 300 
Facile and robust manufacturing methodologies of complex materials, with potential  added value as controlled drug delivery systems, are highly 301 
sought-after in the pharmaceutical industry. In this work, we have demonstrated that supercritical fluid technology in general, and supercritical CO2 in 302 
particular, can be designed as a versatile fabrication route used to obtain highly-porous hybrid (silica:gelatin) aerogels, functionalized with diverse 303 
hydrophobic agents (phenyl, C16 or methyl) and further loaded with an active pharmaceutical ingredient. A considerable high amount of drug was loaded 304 
into the matrices (ca. 15-25, 10-15 and 20-30 wt% for Ibu, Ket and Trf(T), respectively), dispersed in a molecular form inside of the hybrid aerogels, i.e., not 305 
crystallized. For the studied class II BSC weakly acidic drugs, both immediate and semi-retarded release could be achieved based on matrix composition and 306 
surface hydrophobicity. The outcomes of this work are expected to be significant for the pharmaceutical industry, since a large amount of the active agents 307 
in the R&D pipeline fit into class II in the BCS system. These results demonstrate the possibility of tailoring the drug release profile by using complex hybrid 308 
aerogel systems. 309 
 310 
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Figure Captions 419 
Figure 1. Schematic representation of the molecular structure of the used: (a) aerogel modifiers, and (b) drugs. 420 
Figure 2. Selected examples of thermogravimetric profiles recorded for: (a) hydrophilic aerogels with two different gelatin percentages (Table 2), and (b) 421 
hydrophobized H3 aerogels involving Ph, C16 or (CH3)3 silyl moiety. 422 
Figure 3. SEM images of sample H20 at (a) low, and (b) high magnification. 423 
 27 
 
Figure 4. Solid characterization of hybrid H3 aerogels loaded with the three studied drugs: (a) TGA profiles, and (b) XRD patterns. 424 
Figure 5. Influence on drug loading (HPLC calculated, Table 2) of aerogel composition: (a) gelatin ratio, percentage of (b) -Ph or (c) -C16 additive added to H3, 425 
and (d) silylaltion of H3-H30 samples. 426 
Figure 6. Crystalline drugs dissolution profiles at gastric (pH 2.0) and intestinal (pH 6.7) pH-condition: (a)  ibuprofen, (b) ketoprofen, and (c) triflusal. 427 
Figure 7. Release behavior from drug@H3 systems for: (a) ibuprofen at pH 2 and 6.7, (b) ketoprofen at pH 2 and 6.7, (c) triflusal at pH 6.7, and (d) triflusal at 428 
pH 2.  429 
Figure 8. Contrasted drug release profiles from drug@H3 and drug@H3_sil systems for: (a) ibuprofen at pH 6.7 and 2, (b) ketoprofen at pH 6.7 and 2, (c) 430 
triflusal at pH 6.7, and (d) triflusal at pH 2. 431 
 432 
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Table 1 Composition of the precursor mixture for each synthesized aerogel. Data is expressed in grams [g]. 441 
Sample TMOS MeOH H2O (NH4)2CO3Gelatin Ph-TMOS 
C16-
TMOS HMDS 
H3 3.10 5.55 20 0.07 0.10 - - - 
H10 3.10 5.55 20 0.07 0.30 - - - 
H20 3.10 5.55 20 0.07 0.60 - - - 
H30 3.10 5.55 20 0.07 1.00 - - - 
H3_Ph10 2.79 13.5 10 0.10 0.10 0.32 - - 
H3_Ph20 2.48 13.5 10 0.10 0.10 0.64 - - 
H3_Ph30 2.17 13.5 10 0.10 0.10 0.96 - - 
H3_C1610 2.79 13.5 10 0.10 0.10 - 0.27 - 
H3_C1620 2.48 13.5 10 0.10 0.10 - 0.53 - 
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Sample TMOS MeOH H2O (NH4)2CO3Gelatin 
Ph-
TMOS 
C16-
TMOS HMDS 
H3_C1630 2.17 13.5 10 0.10 0.10 - 0.80 - 
H3_Sil 3.10 5.55 20 0.07 0.10 - - 2.31 
H10_Sil 3.10 5.55 20 0.07 0.30 - - 2.31 
H20_Sil 3.10 5.55 20 0.07 0.60 - - 2.31 
H30_Sil 3.10 5.55 20 0.07 1.00 - - 2.31 
Table 2. Composition and textural properties of the precipitated aerogel samples, and HPLC measured drug loading values. 442 
Sample Gelatin (wt%) 
Ph 
(wt%) C16 (wt%)(CH3)3 (wt%)
Sr 
(molecnm-
2) 
as (m2g-
1) C 
Ibu 
(wt%) 
Ket 
(wt%) Trf(T) (wt%)
H3 3.7 0 0 0 0 704 80 24 14 29 
H10 11 0 0 0 0 527 83 23 14 25 
H20 18 0 0 0 0 390 78 22 15 29 
H30 24 0 0 0 0 303 70 19 11 29 
H3_Ph10 5.0 4.2 0 0 0.49 - - 23 18 27 
H3_Ph20 3.8 7.6 0 0 0.84 762 55 19 13 29 
H3_Ph30 4.0 9.2 0 0 1.02 - - 18 9.1 27 
H3_C1610~ 4a 0 2.1 0 0.08 - - 27 11 24 
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Sample Gelatin (wt%) 
Ph 
(wt%) C16 (wt%)(CH3)3 (wt%)
Sr 
(molecnm-
2) 
as (m2g-
1) C 
Ibu 
(wt%) 
Ket 
(wt%) Trf(T) (wt%)
H3_C1620~ 4a 0 4 0 0.17 710 73 25 7.2 21 
H3_C1630~ 4a 0 5.8 0 0.24 - - 25 11 19 
H3_sil 3.6 0 0 6.1 1.16 650 22 15 7.0 18 
H10_sil - - - - - - - 14 7.7 22 
H20_sil 19 0 0 5 1.71 - - 16 9.1 25 
H30_sil 24 0 0 6.5 1.05 - - 15 8.4 26 
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